Program Overview
Structural heart disease encompasses defects in the heart’s valves, walls, or chambers, with the most common types including aortic valve disease, mitral valve disease, as well as tricuspid and pulmonic valve diseases.
The 2024 New York Transcatheter Valves Symposium aims to equip healthcare professionals with the latest developments in diagnosing, managing, and treating valvular and structural heart diseases. This year’s agenda features a dynamic blend of insights from leading clinicians and scholars. Educational sessions will include lectures, live transcatheter procedure transmissions, debates, moderated discussions, and interactive Q&A sessions with our expert faculty.
Additionally, the Structural Heart Fellows Case Competition will highlight exceptional cases in the field, with participants competing for various prizes.
Learning Objectives
- Identify the barriers to care for patients with valvular heart disease, with a focus on addressing current gaps in the timely delivery of percutaneous and surgical interventions.
- Discuss the indications, techniques, outcomes, and potential complications for transcatheter valve interventions in patients with native valve disease and bioprosthetic valve dysfunction.
- Analyze the rationale, challenges, and importance of the heart team approach to valvular heart disease, including the appropriate selection of cases for structural heart intervention.
- Examine the latest and emerging technologies in the management of structural heart disease to evaluate their benefits for patient care.
Target Audience
The New York Valves Symposium has been designed to meet the educational needs of interventional cardiologists, non-invasive cardiologists, cardiothoracic surgeons, heart failure specialists, interventional and imaging fellows-in-training, nurses, technicians and advanced practice professionals who work in structural heart disease.
